Medicare Enrolled

Dr. Shravan Kambam, M.D.

Radiology - Diagnostic · Saddle Brook, NJ
160 PEHLE AVENUE, Saddle Brook, NJ 07663
2018811000
Registered in NPPES since 2006
NPI: 1124055272 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kambam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kambam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kambam

Dr. Shravan Kambam is a radiology - diagnostic specialist in Saddle Brook, NJ, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Kambam received a total of $2,575 from 44 pharmaceutical and/or device companies across 155 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kambam is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $2,575 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,575
Total received (2018-2024)
Avg $368/year across 7 years
Top 18% in NJ for radiology - diagnostic
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
155
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$558
2023
$777
2022
$390
2021
$95
2020
$69
2019
$344
2018
$341

Payments by company (2024)

Incyte Corporation
$73
Janssen Biotech, Inc.
$69
Bayer Healthcare Pharmaceuticals Inc.
$64
Lilly USA, LLC
$60
Merck Sharp & Dohme LLC
$59
GlaxoSmithKline, LLC.
$38
AstraZeneca Pharmaceuticals LP
$37
Novartis Pharmaceuticals Corporation
$33
Daiichi Sankyo Inc.
$32
Emmaus Medical, Inc.
$25
TAIHO ONCOLOGY, INC.
$20
Genentech USA, Inc.
$18
CSL Behring
$16
BioMarin Pharmaceutical Inc.
$14
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$375
Incyte Corporation
$214
Novartis Pharmaceuticals Corporation
$146
Janssen Biotech, Inc.
$143
Amgen Inc.
$133
Bayer Healthcare Pharmaceuticals Inc.
$123
Bayer HealthCare Pharmaceuticals Inc.
$109
Merck Sharp & Dohme LLC
$107
Lilly USA, LLC
$103
Emmaus Medical, Inc.
$96
Daiichi Sankyo Inc.
$79
GlaxoSmithKline, LLC.
$72
Eisai Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$67
TESARO, Inc.
$57
Merck Sharp & Dohme Corporation
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Seagen Inc.
$35
Apellis Pharmaceuticals, Inc.
$32
Bio Products Laboratory USA, Inc.
$32
CSL Behring
$31
Octapharma USA, Inc.
$31
EISAI INC.
$30
Otsuka America Pharmaceutical, Inc.
$29
Celgene Corporation
$28
Partner Therapeutics, Inc.
$26
E.R. Squibb & Sons, L.L.C.
$25
GENZYME CORPORATION
$23
TAIHO ONCOLOGY, INC.
$20
PFIZER INC.
$20
Pharmacosmos Therapeutics Inc.
$20
AVEO Pharmaceuticals, Inc.
$18
MACROGENICS, INC.
$18
Genentech USA, Inc.
$18
Deciphera Pharmaceuticals Inc.
$17
Exelixis Inc.
$17
ARRAY BIOPHARMA INC
$16
Mirati Therapeutics, Inc.
$15
Shire North American Group Inc
$15
Taiho Oncology, Inc.
$15
Rigel Pharmaceuticals, Inc.
$14
BioMarin Pharmaceutical Inc.
$14
Sobi, Inc
$14
Alexion Pharmaceuticals, Inc.
$14
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALTUVIIIO · ALUNBRIG · Aliqopa · CALQUENCE · CYRAMZA · Cabometyx · Coagadex · DARZALEX · DOPTELET · ENHERTU · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FIBRYGA · FOTIVDA · GILOTRIF · HEMGENIX · Halaven · Hemlibra · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kovaltry · Kyprolis · LENVIMA · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Leukine · Lonsurf · MARGENZA · MONOFERRIC · NINLARO · Nplate · Nubeqa · OJJAARA · ONCASPAR · OPDIVO · PADCEV · QINLOCK · ROCTAVIAN · SCEMBLIX · SPRYCEL · Stivarga · TAGRISSO · TECVAYLI · Tavalisse · ULTOMIRIS · VERZENIO · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XYNTHA · Xofigo · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a radiology - diagnostic specialist in Saddle Brook?
Compare radiology - diagnostics in the Saddle Brook area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - diagnostics in nearby ZIP areas
280
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
HACKENSACK UNIVERSITY MEDICAL CENTER
2.7 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kambam is a radiology - diagnostic specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Kambam receive payments from pharmaceutical companies?
Yes. Dr. Kambam received a total of $2,575 from 44 companies across 155 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kambam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Radiology - Diagnostics in Saddle Brook
Browse radiology - diagnostics in Saddle Brook ranked by procedure volume and transparency data.
Highest volume
Top Radiology - Diagnostics in NJ
Radiology - diagnostics ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Radiology - Diagnostics in NJ
Which NJ radiology - diagnostics receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →